ELTX
ELTX
NASDAQ · Biotechnology

Elicio Therapeutics Inc

$1.85
+0.01 (+0.54%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 8 80%
Hold 2 20%
Sell 0 0%
Price Target
Analyst Price Target +1,631.9% upside
Low Target $22.50
Average Target $32.04
High Target $35.39
Current Price $1.85
Current
$1.85
Target
$32.04
$22.50 $32.04 avg $35.39
Scenario Analysis
Bear Case
$22.50
1,116.2%
Low target
Base Case
$32.04
+1,631.9%
Avg target
Bull Case
$35.39
+1,813.0%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$16.00
-88.4% from high
52-Week Low
$1.71
+8.5% from low
Target vs 52W High
$32.04
+100.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%